Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2004 4
2005 5
2006 11
2007 9
2008 11
2009 13
2010 17
2011 14
2012 21
2013 17
2014 15
2015 18
2016 23
2017 29
2018 26
2019 28
2020 17
2021 11
Text availability
Article attribute
Article type
Publication date

Search Results

251 results
Results by year
Filters applied: . Clear all
Page 1
Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial.
Verma S, Mazer CD, Yan AT, Mason T, Garg V, Teoh H, Zuo F, Quan A, Farkouh ME, Fitchett DH, Goodman SG, Goldenberg RM, Al-Omran M, Gilbert RE, Bhatt DL, Leiter LA, Jüni P, Zinman B, Connelly KA. Verma S, et al. Among authors: yan at. Circulation. 2019 Nov 19;140(21):1693-1702. doi: 10.1161/CIRCULATIONAHA.119.042375. Epub 2019 Aug 22. Circulation. 2019. PMID: 31434508 Clinical Trial.
Effect of Empagliflozin on Erythropoietin Levels, Iron Stores, and Red Blood Cell Morphology in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease.
Mazer CD, Hare GMT, Connelly PW, Gilbert RE, Shehata N, Quan A, Teoh H, Leiter LA, Zinman B, Jüni P, Zuo F, Mistry N, Thorpe KE, Goldenberg RM, Yan AT, Connelly KA, Verma S. Mazer CD, et al. Among authors: yan at. Circulation. 2020 Feb 25;141(8):704-707. doi: 10.1161/CIRCULATIONAHA.119.044235. Epub 2019 Nov 11. Circulation. 2020. PMID: 31707794 No abstract available.
SGLT2 Inhibition with Empagliflozin Increases Circulating Provascular Progenitor Cells in People with Type 2 Diabetes Mellitus.
Hess DA, Terenzi DC, Trac JZ, Quan A, Mason T, Al-Omran M, Bhatt DL, Dhingra N, Rotstein OD, Leiter LA, Zinman B, Sabongui S, Yan AT, Teoh H, Mazer CD, Connelly KA, Verma S. Hess DA, et al. Among authors: yan at. Cell Metab. 2019 Oct 1;30(4):609-613. doi: 10.1016/j.cmet.2019.08.015. Epub 2019 Aug 30. Cell Metab. 2019. PMID: 31477497 Free article. Clinical Trial.
Sarak B, Wald R, Yan AT. Sarak B, et al. Among authors: yan at. J Hypertens. 2017 Dec;35(12):2553-2554. doi: 10.1097/HJH.0000000000001552. J Hypertens. 2017. PMID: 29095237 No abstract available.
Effects of Empagliflozin on Left Ventricular Remodeling in Patients with Type 2 Diabetes and Coronary Artery Disease: Echocardiographic Substudy of the EMPA-HEART CardioLink-6 Randomized Clinical Trial.
Bami K, Gandhi S, Leong-Poi H, Yan AT, Ho E, Zahrani M, Garg V, Zuo F, Teoh H, Quan A, Leiter LA, Gilbert RE, Zinman B, Thorpe KE, Jüni P, Mazer CD, Verma S, Ong G, Connelly KA. Bami K, et al. Among authors: yan at. J Am Soc Echocardiogr. 2020 May;33(5):644-646. doi: 10.1016/j.echo.2020.02.005. Epub 2020 Mar 18. J Am Soc Echocardiogr. 2020. PMID: 32199780 No abstract available.
Serial Cardiovascular Magnetic Resonance Strain Measurements to Identify Cardiotoxicity in Breast Cancer: Comparison With Echocardiography.
Houbois CP, Nolan M, Somerset E, Shalmon T, Esmaeilzadeh M, Lamacie MM, Amir E, Brezden-Masley C, Koch CA, Thevakumaran Y, Yan AT, Marwick TH, Wintersperger BJ, Thavendiranathan P. Houbois CP, et al. Among authors: yan at. JACC Cardiovasc Imaging. 2021 May;14(5):962-974. doi: 10.1016/j.jcmg.2020.09.039. Epub 2020 Nov 25. JACC Cardiovasc Imaging. 2021. PMID: 33248962
Stress cardiac MRI in stable coronary artery disease.
Ge Y, Deva DP, Connelly KA, Yan AT. Ge Y, et al. Among authors: yan at. Curr Opin Cardiol. 2020 Sep;35(5):566-573. doi: 10.1097/HCO.0000000000000776. Curr Opin Cardiol. 2020. PMID: 32649360 Review.
251 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page